GeoVax receives Nasdaq delisting notice over bid price; trading suspension expected Sept 8

GeoVax Labs, Inc.

• On Aug 27, 2026, Nasdaq Staff determined to delist GOVX common stock due to bid price below $1.00 for 30 consecutive trading days (Jul 16-Aug 26).
• 1-for-25 reverse split on Jan 12, 2026 makes company ineligible for 180-day compliance period under Rule 5810(c)(3)(A)(iv).
• Also previously non-compliant with $2.5M stockholders' equity requirement (Rule 5550(b)).
• Trading expected suspended at open Sept 8, 2026; company will request hearing before Sept 3 deadline to stay suspension.
• No assurance Hearings Panel will grant continued listing; shares remain listed during appeal.